BR112018000396A2 - composições de nicergolina de liberação modificada - Google Patents

composições de nicergolina de liberação modificada

Info

Publication number
BR112018000396A2
BR112018000396A2 BR112018000396A BR112018000396A BR112018000396A2 BR 112018000396 A2 BR112018000396 A2 BR 112018000396A2 BR 112018000396 A BR112018000396 A BR 112018000396A BR 112018000396 A BR112018000396 A BR 112018000396A BR 112018000396 A2 BR112018000396 A2 BR 112018000396A2
Authority
BR
Brazil
Prior art keywords
nicergoline
compositions
modified release
release
modified
Prior art date
Application number
BR112018000396A
Other languages
English (en)
Inventor
Garg Amit
Kumar Padhi Bijay
Singh Raghuvanshi Rajeev
Srivastava Saurabh
Original Assignee
Dr Reddys Laboratories Ltd
Kunshan Rotam Reddy Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Kunshan Rotam Reddy Pharmaceutical Co Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of BR112018000396A2 publication Critical patent/BR112018000396A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112018000396A 2015-07-08 2016-07-08 composições de nicergolina de liberação modificada BR112018000396A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510397017.XA CN106333927A (zh) 2015-07-08 2015-07-08 修饰释放的尼麦角林组合物
PCT/IB2016/054111 WO2017006290A1 (en) 2015-07-08 2016-07-08 Modified release nicergoline compositions

Publications (1)

Publication Number Publication Date
BR112018000396A2 true BR112018000396A2 (pt) 2018-09-11

Family

ID=56740271

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018000396A BR112018000396A2 (pt) 2015-07-08 2016-07-08 composições de nicergolina de liberação modificada

Country Status (5)

Country Link
EP (1) EP3426231A1 (pt)
CN (1) CN106333927A (pt)
BR (1) BR112018000396A2 (pt)
RU (1) RU2018104691A (pt)
WO (1) WO2017006290A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111904938A (zh) * 2020-05-15 2020-11-10 山东方明药业集团股份有限公司 一种尼麦角林片剂的制备方法
CN113081993A (zh) * 2021-04-15 2021-07-09 海南通用三洋药业有限公司 一种尼麦角林片剂的制备方法
CN113358790B (zh) * 2021-06-10 2022-11-11 河北嘉迈医药科技有限公司 一种尼麦角林及其制剂中有关物质的检测方法
CN113398089A (zh) * 2021-06-29 2021-09-17 海南通用三洋药业有限公司 一种尼麦角林胶囊的制备方法和尼麦角林胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256743B (it) 1992-12-18 1995-12-15 Giorgio Pifferi Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
CN1921839A (zh) * 2004-01-19 2007-02-28 兰贝克赛实验室有限公司 加巴喷丁的稳定缓释口服剂型及其制备方法
CN101095663A (zh) 2006-06-28 2008-01-02 黑龙江大学 尼麦角林缓释胶囊及其制备方法
CN101269035A (zh) 2008-05-16 2008-09-24 北京正大绿洲医药科技有限公司 尼麦角林缓释滴丸及其制备方法
CN102949372A (zh) * 2011-08-26 2013-03-06 山东方明药业集团股份有限公司 一种尼麦角林片及其制备方法
RU2491070C2 (ru) * 2011-10-11 2013-08-27 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция для профилактики и лечения сердечно-сосудистых заболеваний

Also Published As

Publication number Publication date
EP3426231A1 (en) 2019-01-16
RU2018104691A (ru) 2019-08-09
WO2017006290A1 (en) 2017-01-12
CN106333927A (zh) 2017-01-18
RU2018104691A3 (pt) 2019-11-27

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
DK3361870T3 (da) Fungicidsammensætninger
DK3151672T3 (da) Forbedrede t-celle-sammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3542812T3 (da) Glycopeptidsammensætninger
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
BR112016023341A2 (pt) composição desinfetante de ação rápida
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
MA50657A (fr) Formulations de niraparib
ES2796177T5 (es) Composición farmacéutica
FR3024363B1 (fr) Composition thermogelifiable
DK3377634T3 (da) Bakteriebaseret proteinafgivelse
DK3528902T3 (da) Ringegelsammensætning
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
DK3331498T3 (da) Nasalsammensætning
FR3020948B1 (fr) Composition antimicrobienne
DK3316857T3 (da) Multifasiske sammensætninger
MA50068A (fr) Formulations de copanlisib
BR112018000396A2 (pt) composições de nicergolina de liberação modificada
DK3393254T3 (da) Sammensætning
DK3200827T3 (da) Sammensætninger
DK3528791T3 (da) Dispergible sammensætninger
DK3416502T3 (da) Glykæmisk-reducerende sammensætning

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2703 DE 25/10/2022.